Skip to content
Screener

uniQure QURE Accrued Expenses

Accrued Expenses at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$16.56M+59.0%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$16.81M+38.4%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$89K-96.7%
Opus Genetics logo
Opus GeneticsIRD
$795K+54.4%
Arvinas logo
ArvinasARVN
$4.5M-40.8%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$15M+481%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.2B+312%
Enterprise value$2.84B+384%
P/S171.1×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemJune 30, 2026December 31, 2025
Total assets$985,103$824,908
Current liabilities
Accounts payable$4,979$5,170
Accrued expenses and other current liabilities51,13341,292
Liability related to pre-funded warrants24,24212,595
Current portion of operating lease liabilities2,9913,862
Total current liabilities83,34562,919
Non-current liabilities

Item 1.Financial Statements

FAQ

What is uniQure's accrued expenses?
uniQure (QURE) reported accrued expenses of $51.13M in Q2 2026.
How has uniQure's accrued expenses changed year-over-year?
uniQure's accrued expenses increased by 62.4% year-over-year, from $31.48M to $51.13M.
What is the long-term trend for uniQure's accrued expenses?
Over 5 years (2020 to 2025), uniQure's accrued expenses has grown at a 18.0% compound annual growth rate (CAGR), from $18.04M to $41.29M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about uniQure's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude